Paradoxical response to tuberculosis treatment in a patient receiving tumor necrosis factor-alpha antagonist.
暂无分享,去创建一个
E. Coche | J. Yombi | D. Wilmes | P. Hainaut | L. Pothen | Caroline Moureau
[1] G. Carcelain,et al. Paradoxical exacerbation of tuberculosis after TNFα antagonist discontinuation: beware of immune reconstitution inflammatory syndrome. , 2011, Joint, bone, spine : revue du rhumatisme.
[2] E. Medina,et al. Immune reconstitution inflammatory syndrome after cessation of the tumor necrosis factor alpha blocker adalimumab in cryptococcal pneumonia. , 2009, Diagnostic microbiology and infectious disease.
[3] P. Reiss,et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. , 2008, The Lancet. Infectious diseases.
[4] E. Leyten,et al. A patient with de novo tuberculosis during anti-tumor necrosis factor-alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] E. Vicaut,et al. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients , 2006, AIDS.
[6] J. Garau,et al. Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.